Gan & Lee Insulins Data Is Boon For Sandoz
Three Biosimilar Candidates Meet Primary Analyses
Celebrating a “major milestone in the biosimilar clinical development programs,” Gan & Lee has just presented positive data at the recent at the Scientific Sessions of the American Diabetes Association.
